Tetra Bio-Pharma

Therapeutic Areas

Tetra is developing medicines targeting the following areas:

Inflammation

  • Cytokine Release Syndrome (CAR-T)
  • Sepsis
  • Acute Respiratory Distress Syndrome

Pain

  • Chronic Lower Back Pain
  • Breakthrough Lower Back Pain
  • Breakthrough Cancer Pain
  • Uncontrolled Cancer Pain

Oncology

  • CAR-T
  • Chemo Induced Nausea and Vomiting
  • Cancer Cachexia
  • Hepatocellular Carcinoma

Staying Ahead of the Curve

As the opioid epidemic affects millions in North America and continues to grow, there is an increasing demand for an alternative to opioids such as cannabis-based drugs that will replace the toxic and addictive side effect profile of opioids. Tetra Bio-Pharma is dedicated to conducting rigorous clinical trials with the goal of commercializing products on the foundation of scientific evidence. Tetra Bio-Pharma is a Canadian-based company that has several subsidiaries engaged in the development of an advanced and growing pipeline of biopharmaceuticals, natural health and veterinary products containing cannabinoid-derived molecules and other medicinal plant-based elements.

Patient Centered Innovation

Tetra uses novel approaches and technologies to enhance patient quality of life.

Unique Mechanisms of Action

Tetra leverages unconventional mechanisms of action to address unmet needs.

High Quality Delivery Methods

Tetra is dedicated to finding the best way to deliver its drugs.